Voclosporin - Latest Advances

Safety assessment of voclosporin: a real-world disproportionality analysis of the FAERS database.

Journal: Immunopharmacology and immunotoxicology

Published: October 16, 2025

Response: Does baseline nephrotic range proteinuria determine the long-term outcomes of membranous lupus nephritis patients? Reply Letter to Capuano et al. (Letter to the Editor: Voclosporin in Late Onset Lupus Nephritis with Anti-PLA2R Antibodies).

Journal: Seminars in arthritis and rheumatism

Published: September 10, 2025

Refractory Lupus Podocytopathy: The Role of Repeat Biopsy and Rituximab.

Journal: Cureus

Published: September 08, 2025

Efficacy and safety of Belimumab, Rituximab and Voclosporin in the treatment of lupus nephritis based on registered clinical trials: A systematic review and network meta-analysis.

Journal: Lupus

Published: September 05, 2025

Phase IV safety evaluation of voclosporin in lupus nephritis patients using the FAERS database for a 42-month period (2021 - 2024).

Journal: International journal of clinical pharmacology and therapeutics

Published: September 01, 2025

"Voclosporin in late onset lupus nephritis with anti-PLA2R antibodies".

Journal: Seminars in arthritis and rheumatism

Published: August 11, 2025

Precision Editing of Cyclophilin A Generates Cyclosporine and Voclosporin Resistant Cellular Therapies.

Journal: bioRxiv : the preprint server for biology

Published: July 14, 2025

Voclosporin: A comprehensive review of its role as a novel calcineurin inhibitor in the management of systemic lupus erythematosus.

Journal: Medicine

Published: June 23, 2025

Systematic Review and Network Meta-Analysis of Initial Treatments for Lupus Nephritis.

Journal: Kidney international reports

Published: May 02, 2025

Reply to: "Current Use of PBPK Modeling in New Medicinal Product Approvals at EMA: A Clinical Appraisal of Voclosporin in Lupus Nephritis".

Journal: Clinical pharmacology and therapeutics

Published: May 02, 2025

Combination Therapy With Voclosporin and Anifrolumab in Two Patients With Lupus Nephritis and Discoid Lupus Erythematosus.

Journal: Cureus

Published: May 01, 2025

Development and Application of a Senolytic Predictor for Discovery of Novel Senolytic Compounds and Herbs.

Journal: Molecules (Basel, Switzerland)

Published: April 22, 2025

Filters

Safety assessment of voclosporin: a real-world disproportionality analysis of the FAERS database.

Safety assessment of voclosporin: a real-world disproportionality analysis of the FAERS database.

Response: Does baseline nephrotic range proteinuria determine the long-term outcomes of membranous lupus nephritis patients? Reply Letter to Capuano et al. (Letter to the Editor: Voclosporin in Late Onset Lupus Nephritis with Anti-PLA2R Antibodies).

Response: Does baseline nephrotic range proteinuria determine the long-term outcomes of membranous lupus nephritis patients? Reply Letter to Capuano et al. (Letter to the Editor: Voclosporin in Late Onset Lupus Nephritis with Anti-PLA2R Antibodies).

Refractory Lupus Podocytopathy: The Role of Repeat Biopsy and Rituximab.

Refractory Lupus Podocytopathy: The Role of Repeat Biopsy and Rituximab.

Efficacy and safety of Belimumab, Rituximab and Voclosporin in the treatment of lupus nephritis based on registered clinical trials: A systematic review and network meta-analysis.

Efficacy and safety of Belimumab, Rituximab and Voclosporin in the treatment of lupus nephritis based on registered clinical trials: A systematic review and network meta-analysis.

Phase IV safety evaluation of voclosporin in lupus nephritis patients using the FAERS database for a 42-month period (2021 - 2024).

Phase IV safety evaluation of voclosporin in lupus nephritis patients using the FAERS database for a 42-month period (2021 - 2024).

"Voclosporin in late onset lupus nephritis with anti-PLA2R antibodies".

"Voclosporin in late onset lupus nephritis with anti-PLA2R antibodies".

Precision Editing of Cyclophilin A Generates Cyclosporine and Voclosporin Resistant Cellular Therapies.

Precision Editing of Cyclophilin A Generates Cyclosporine and Voclosporin Resistant Cellular Therapies.

Voclosporin: A comprehensive review of its role as a novel calcineurin inhibitor in the management of systemic lupus erythematosus.

Voclosporin: A comprehensive review of its role as a novel calcineurin inhibitor in the management of systemic lupus erythematosus.

Systematic Review and Network Meta-Analysis of Initial Treatments for Lupus Nephritis.

Systematic Review and Network Meta-Analysis of Initial Treatments for Lupus Nephritis.

Reply to: "Current Use of PBPK Modeling in New Medicinal Product Approvals at EMA: A Clinical Appraisal of Voclosporin in Lupus Nephritis".

Reply to: "Current Use of PBPK Modeling in New Medicinal Product Approvals at EMA: A Clinical Appraisal of Voclosporin in Lupus Nephritis".

Combination Therapy With Voclosporin and Anifrolumab in Two Patients With Lupus Nephritis and Discoid Lupus Erythematosus.

Combination Therapy With Voclosporin and Anifrolumab in Two Patients With Lupus Nephritis and Discoid Lupus Erythematosus.

Development and Application of a Senolytic Predictor for Discovery of Novel Senolytic Compounds and Herbs.

Development and Application of a Senolytic Predictor for Discovery of Novel Senolytic Compounds and Herbs.